Parallax Volatility Advisers, L.P. Cure Vac N.V. Put Options Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	SELL	$13.18 - $19.41 $193,746 - $285,327	-14,700 Reduced 30.82%	33,000 $449,000
Q1 2022 May 16, 2022	SELL	$14.73 - $35.25 $2.61 Million - $6.24 Million	-176,900 Reduced 78.76%	47,700 $935,000
Q4 2021 Feb 14, 2022	SELL	$33.72 - $48.22 $1.65 Million - $2.36 Million	-49,000 Reduced 17.91%	224,600 $7.7 Million
Q3 2021 Nov 15, 2021	BUY	$49.26 - $74.5 $4.26 Million - $6.44 Million	86,500 Added 46.23%	273,600 $14.9 Million
Q2 2021 Aug 16, 2021	BUY	$56.91 - $127.53 $10.6 Million - $23.9 Million	187,100 New	187,100 $13.7 Million

102

14.2M

270K

114K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $1B
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.